SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-212159
Filing Date
2019-08-02
Accepted
2019-08-02 17:26:29
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d624539ds3.htm S-3 463231
2 EX-1.2 d624539dex12.htm EX-1.2 215100
3 EX-4.3 d624539dex43.htm EX-4.3 536396
4 EX-4.4 d624539dex44.htm EX-4.4 576588
5 EX-5.1 d624539dex51.htm EX-5.1 14486
6 EX-5.2 d624539dex52.htm EX-5.2 7212
7 EX-23.1 d624539dex231.htm EX-23.1 1600
8 GRAPHIC g624539g09o87.jpg GRAPHIC 65924
9 GRAPHIC g624539g74w05.jpg GRAPHIC 65716
  Complete submission text file 0001193125-19-212159.txt   1997233
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232999 | Film No.: 19996996
SIC: 2834 Pharmaceutical Preparations